Stop gonadotropin-releasing hormone-agonist protocol not superior to antagonist protocol on the outcomes of assisted reproductive techniques in poor responders: A randomized clinical trial

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 15

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJRM-24-7_006

تاریخ نمایه سازی: 18 مهر 1405

چکیده مقاله:

Background: Poor ovarian response remains one of the most challenging problems in assisted reproductive technology. Various stimulation protocols have been proposed to improve outcomes, including combined gonadotropin-releasing hormone (GnRH) agonist and antagonist strategies. Objective: To compare the effectiveness of a stop GnRH-agonist protocol combined with a GnRH-antagonist protocol vs. a standard GnRH-antagonist protocol in poor ovarian responder (POR) cases. Materials and Methods: This randomized clinical trial was conducted on ۱۰۰ women aged ۱۸-۴۴ yr diagnosed as POR according to the Bologna criteria. Participants were randomly allocated to either a GnRH-antagonist protocol (control group) or a combined Stop GnRH-agonist/GnRH-antagonist protocol (intervention group). The primary outcome was the clinical pregnancy rate. Secondary outcomes included the number of retrieved oocytes, embryo quality, chemical pregnancy, and live birth rate. Results: No statistically significant differences were observed between the ۲ groups regarding chemical pregnancy, clinical pregnancy, or live birth rates. Laboratory outcomes, including the number of retrieved oocytes, metaphase II oocytes, and embryo quality, were also comparable. The intervention group required a significantly higher gonadotropin dose and had a longer stimulation duration (p < ۰.۰۱). Conclusion: The stop GnRH-agonist protocol did not demonstrate superiority over the GnRH-antagonist protocol in terms of laboratory or clinical outcomes in POR cases.

کلیدواژه ها:

Poor ovarian responders ، Controlled ovarian hyperstimulation ، Bologna criteria ، Stop GnRH-agonist protocol ، GnRH-antagonist. ، پاسخ دهندگان ضعیف تخمدانی ، تحریک کنترل شده تخمدان ، معیارهای بولونیا ، پروتکل توقف آگونیست GnRH ، آنتاگونیست GnRH.

نویسندگان

Saeideh Dashti

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Robab Davar

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Fatemeh Emami

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Farimah Shamsi

Department of Biostatistics and Epidemiology, Center for Health Data Modeling, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Esmat Mangoli

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Blumenfeld Z. What is the best regimen for ovarian stimulation ...
  • Jeve YB, Bhandari HM. Effective treatment protocol for poor ovarian ...
  • Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund ...
  • Haas J, Zilberberg E, Machtinger R, Kedem A, Hourvitz A, ...
  • Gonda KJ, Domar AD, Gleicher N, Marrs RP. Insights from ...
  • Ferraretti AP, Gianaroli L. The Bologna criteria for the definition ...
  • Lokshin V, Valiev R, Rybina A, Zaichenko K. “Poor responders”-modern ...
  • Mauries C, Ranisavljevic N, Mollevi C, Brunet C, Hamamah S, ...
  • Morales Berrocal MM, Peña Miranda M, Roque Sánchez AM. Case ...
  • Orvieto R, Nahum R, Frei J, Zandman O, Frenkel Y, ...
  • Qin Y. Effects of using letrozole in combination with the ...
  • Abbasi F, Davar R, Shamsi F, Dashti S. Insulin-like growth ...
  • Orvieto R, Kirshenbaum M, Galiano V, Elkan-Miller T, Zilberberg E, ...
  • Homayoon N, Arabian S, Mangoli E, Bayati F, Eftekhar M. ...
  • Bahrami F, Dashti S, Mangoli E, Hosseini HS. Does body ...
  • Ebrahimpoor M, Dehghani Firouzabadi R, Javaheri A, Shamsi F, Dashti ...
  • Orvieto R, Kirshenbaum M, Galiano V, Haas J, Nahum R. ...
  • Orvieto R, Nahum R, Aizer A, Haas J, Kirshenbaum M. ...
  • Orvieto R. Stop GnRH-agonist/GnRH-antagonist protocol: A different insight on ovarian ...
  • Saharkhiz N, Hosseini S, Kazemi M, Majdi L, Esmaeili S, ...
  • Li S, Zhou D, Yin T, Xu W, Xie Q, ...
  • Maheshwari A, Gibreel A, Siristatidis CS, Bhattacharya S. Gonadotrophin‐releasing hormone ...
  • Tong F, Wang Y, Gao Q, Zhao Y, Zhang X, ...
  • Yang S, Liu N, Li Y, Zhang L, Yue R. ...
  • Oudendijk JF, Yarde F, Eijkemans MJC, Broekmans FJM, Broer SL. ...
  • نمایش کامل مراجع